1-14 of 14
Eva Szabo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A021: Pilot study of daily exemestane in patients with Endometrial Intraepithelial Neoplasia (EIN) or grade 1 endometrial cancer

Free
Britt K. Erickson, Lisa Barrioullet, Rebecca C. Arend, Dina El-Rayes, Mahmoud Khalifa, Amy Skubitz, Kristin Boylan, Andrew Nelson, Bharat Thyagarajan, Thomas Havighurst, Richard Chappell, Eileen Dimond, Katina Deshong, Goli Samimi, Eva Szabo, Howard Bailey
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (5_Supplement): A021.
https://doi.org/10.1158/1557-3265.ENDO24-A021
Published: 01 March 2024
View articletitled, Abstract A021: Pilot study of daily exemestane in patients with Endometrial Intraepithelial Neoplasia (EIN) or grade 1 endometrial cancer
Journal Articles

Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma

Available to Purchase
Robert E. Schoen, Lisa A. Boardman, Marcia Cruz-Correa, Ajay Bansal, David Kastenberg, Chin Hur, Lynda Dzubinski, Sharon F. Kaufman, Luz M. Rodriguez, Ellen Richmond, Asad Umar, Eva Szabo, Andres Salazar, John McKolanis, Pamela Beatty, Reetesh K. Pai, Aatur D. Singhi, Camille M. Jacqueline, Riyue Bao, Brenda Diergaarde, Ryan P. McMurray, Carrie Strand, Nathan R. Foster, David M. Zahrieh, Paul J. Limburg, Olivera J. Finn
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1678–1688.
https://doi.org/10.1158/1078-0432.CCR-22-3168
Published: 01 May 2023
View articletitled, Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma
Open the PDF for Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma in another window
Includes: Supplementary data
Journal Articles

Targeting mTOR in Head and Neck Cancer—Response

Free
J. Silvio Gutkind, Terry A. Day, Scott M. Lippman, Eva Szabo
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6555.
https://doi.org/10.1158/1078-0432.CCR-19-2002
Published: 01 November 2019
View articletitled, Targeting mTOR in Head and Neck Cancer—Response
Open the PDF for Targeting mTOR in Head and Neck Cancer—Response in another window
Journal Articles

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial

Free
Terry A. Day, Keisuke Shirai, Paul E. O'Brien, Maria Gisele Matheus, Kristina Godwin, Amit J. Sood, Anvesh Kompelli, Julie A. Vick, Daniel Martin, Lynn Vitale-Cross, Juan Luis Callejas-Varela, Zhiyong Wang, Xingyu Wu, Olivier Harismendy, Alfredo A. Molinolo, Scott M. Lippman, Carter Van Waes, Eva Szabo, J. Silvio Gutkind
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1156–1164.
https://doi.org/10.1158/1078-0432.CCR-18-2024
Published: 15 February 2019
View articletitled, Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial
Open the PDF for Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial in another window
Includes: Supplementary data
Journal Articles

AACR Cancer Progress Report 2015

Free
José Baselga, Nina Bhardwaj, Lewis C. Cantley, Ronald DeMatteo, Raymond N. DuBois, Margaret Foti, Susan M. Gapstur, William C. Hahn, Lee J. Helman, Roy A. Jensen, Electra D. Paskett, Theodore S. Lawrence, Stuart G. Lutzker, Eva Szabo
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19_Supplement): S1–S128.
https://doi.org/10.1158/1078-0432.CCR-15-1846
Published: 30 September 2015
View articletitled, AACR Cancer Progress Report 2015
Open the PDF for AACR Cancer Progress Report 2015 in another window
Includes: Supplementary data
Journal Articles

A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study

Free
Anish Thomas, Arun Rajan, Eva Szabo, Yusuke Tomita, Corey A. Carter, Barbara Scepura, Ariel Lopez-Chavez, Min-Jung Lee, Christophe E. Redon, Ari Frosch, Cody J. Peer, Yuanbin Chen, Richard Piekarz, Seth M. Steinberg, Jane B. Trepel, William D. Figg, David S. Schrump, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (21): 5392–5402.
https://doi.org/10.1158/1078-0432.CCR-14-0968
Published: 30 October 2014
View articletitled, A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study
Open the PDF for A Phase I/II Trial of Belinostat in Combination with Cisplatin, Doxorubicin, and Cyclophosphamide in Thymic Epithelial Tumors: A Clinical and Translational Study in another window
Includes: Supplementary data
Journal Articles

Deregulation of the phosphatidylinositol 3-kinase pathway in the airway epithelium of smokers is associated with lung cancer

Free
Adam Gustafson, Stephen Lam, Annette McWilliams, Eva Szabo, Jerome Brody, Andrea Bild, Avrum Spira
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): PR-4.
Published: 15 August 2014
View articletitled, Deregulation of the phosphatidylinositol 3-kinase pathway in the airway epithelium of smokers is associated with lung cancer
Journal Articles

18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors

Free
Anish Thomas, Esther Mena, Karen Kurdziel, David Venzon, Sean Khozin, Arlene W. Berman, Peter Choyke, Eva Szabo, Arun Rajan, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1487–1493.
https://doi.org/10.1158/1078-0432.CCR-12-2929
Published: 14 March 2013
View articletitled, 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors
Open the PDF for 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors in another window
Includes: Supplementary data
Journal Articles

A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors

Free
Arun Rajan, Corey A. Carter, Ronan J. Kelly, Martin Gutierrez, Shivaani Kummar, Eva Szabo, Mary Ann Yancey, Jiuping Ji, Baskar Mannargudi, Sukyung Woo, Shawn Spencer, William Douglas Figg, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (8): 2344–2351.
https://doi.org/10.1158/1078-0432.CCR-11-2425
Published: 16 April 2012
View articletitled, A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors
Open the PDF for A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer

Free
Jiping Chen, Stephen Lam, Aprile Pilon, Annette McWilliams, Calum MacAulay, Eva Szabo
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1590–1597.
https://doi.org/10.1158/1078-0432.CCR-07-4066
Published: 03 March 2008
View articletitled, Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer
Open the PDF for Higher Levels of the Anti-inflammatory Protein CC10 Are Associated with Improvement in Bronchial Dysplasia and Sputum Cytometric Assessment in Individuals at High Risk for Lung Cancer in another window
Journal Articles

Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward

Free
Gary J. Kelloff, Scott M. Lippman, Andrew J. Dannenberg, Caroline C. Sigman, Homer L. Pearce, Brian J. Reid, Eva Szabo, V. Craig Jordan, Margaret R. Spitz, Gordon B. Mills, Vali A. Papadimitrakopoulou, Reuben Lotan, Bharat B. Aggarwal, Robert S. Bresalier, Jeri Kim, Banu Arun, Karen H. Lu, Melanie E. Thomas, Helen E. Rhodes, Molly A. Brewer, Michele Follen, Dong M. Shin, Howard L. Parnes, Jill M. Siegfried, Alison A. Evans, William J. Blot, Wong-Ho Chow, Patricia L. Blount, Carlo C. Maley, Kenneth K. Wang, Stephen Lam, J. Jack Lee, Steven M. Dubinett, Paul F. Engstrom, Frank L. Meyskens, Jr., Joyce O'Shaughnessy, Ernest T. Hawk, Bernard Levin, William G. Nelson, Waun Ki Hong, for the AACR Task Force on Cancer Prevention
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (12): 3661–3697.
https://doi.org/10.1158/1078-0432.CCR-06-1104
Published: 15 June 2006
View articletitled, Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward
Open the PDF for Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move Forward in another window
Journal Articles

A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors

Free
Maurice A. Wright, Geraldine Morrison, Pengxin Lin, Gregory D. Leonard, Dat Nguyen, Xaiodu Guo, Eva Szabo, Jon L. Hopkins, Jorge P. Leguizamo, Nancy Harold, Suzanne Fioravanti, Barbara Schuler, Brian P. Monahan, M. Wasif Saif, Mary G. Quinn, Janet Pang, Jean L. Grem
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (11): 4144–4150.
https://doi.org/10.1158/1078-0432.CCR-04-2439
Published: 01 June 2005
View articletitled, A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors
Open the PDF for A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors in another window
Journal Articles

A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium

Free
Stephen Lam, Jean C. leRiche, Annette McWilliams, Calum MacAulay, Yulia Dyachkova, Eva Szabo, John Mayo, Robert Schellenberg, Andy Coldman, Ernest Hawk, Adi Gazdar
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6502–6511.
https://doi.org/10.1158/1078-0432.CCR-04-0686
Published: 08 October 2004
View articletitled, A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium
Open the PDF for A Randomized Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) in People with Dysplasia of the Bronchial Epithelium in another window
Journal Articles

Enhanced Growth Inhibition by Combination Differentiation Therapy with Ligands of Peroxisome Proliferator-activated Receptor-γ and Inhibitors of Histone Deacetylase in Adenocarcinoma of the Lung

Free
Tsg-Hui Chang, Eva Szabo
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1206–1212.
Published: 01 April 2002
View articletitled, Enhanced Growth Inhibition by Combination Differentiation Therapy with Ligands of Peroxisome Proliferator-activated Receptor-γ and Inhibitors of Histone Deacetylase in Adenocarcinoma of the Lung
Open the PDF for Enhanced Growth Inhibition by Combination Differentiation Therapy with Ligands of Peroxisome Proliferator-activated Receptor-γ and Inhibitors of Histone Deacetylase in Adenocarcinoma of the Lung in another window